Trifluoromethyldeschloroketamine
Chemical compound
- none
- CA: Schedule I
- UK: Under Psychoactive Substances Act
- 2-(methylamino)-2-[2-(trifluoromethyl)phenyl]cyclohexan-1-one
- 1782149-73-8
Y
- 117067835
- GW3LZ66WZ6
- Interactive image
- CNC1(CCCCC1=O)C2=CC=CC=C2C(F)(F)F
InChI
- InChI=1S/C14H16F3NO/c1-18-13(9-5-4-8-12(13)19)10-6-2-3-7-11(10)14(15,16)17/h2-3,6-7,18H,4-5,8-9H2,1H3
- Key:LETHPPJNGNSLDJ-UHFFFAOYSA-N
Trifluoromethyldeschloroketamine (TFMDCK) is a designer drug from the arylcyclohexylamine family, which is presumed to have similar properties to ketamine, a dissociative anesthetic drug with hallucinogenic and sedative effects. It has been sold over the internet since around 2016, though genuine samples appear to be rare.[1] The o-trifluoromethyl analogue of hydroxynorketamine has also been researched as an antidepressant.[2]
See also
References
- ^ Wallach J, Brandt SD (2018). "1,2-Diarylethylamine- and Ketamine-Based New Psychoactive Substances". New Psychoactive Substances. Handbook of Experimental Pharmacology. Vol. 252. pp. 305–352. doi:10.1007/164_2018_148. ISBN 978-3-030-10560-0. PMID 30196446.
- ^ 种长效化合物的制备方法. Chinese patent CN 110540510A, 18 June 2019
 | This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e
